Exclusive Interview with Organigram CEO Greg Engel In 2018, Organigram (NASDAQ: OGI) (TSX: OGI) CEO Greg Engel spoke with New Cannabis Ventures about creating a company culture of quality....
Exclusive Interview with Organigram CEO Greg Engel Organigram (TSXV: OGI) (OTC: OGRMF) found itself at a turning point at the end of 2016. The licensed Canadian medical marijuana producer...
New Cannabis Ventures helped spearhead the Exclusive Public Companies Symposium at New West Summit in Oakland on October 13-14th. The goal of the event was to introduce leading public cannabis companies to...
Greg Engel Appointed OrganiGram CEO, Denis Arsenault Steps up as Executive Chairman MONCTON, NEW BRUNSWICK–(Marketwired – March 1, 2017) – Organigram Holdings Inc. (TSX VENTURE:OGI) (OTC:OGRMF) (the “Company”) has...
Greg Engel, the former pharmaceutical executive who was named as CEO of Canadian licensed cannabis producer Tilray earlier this year, wrote an editorial that was published by the National...
The federal Liberals’ campaign promise to legalize recreational pot will likely shake up the economics of both the black market and medical cannabis industries, say experts. But B.C. marijuana...
One of the highlights of the National Cannabis Summit in Denver was the 90-minute panel entitled “Investing in the Canadian Cannabis Sector”. The participants included the CEO of merchant...
Medical marijuana producers are bracing for the possibility that Canadians could elect a new government this fall — a change that could accelerate the already breakneck pace of growth...
